CHARACTERISTICS OF YOUNG ILLICIT DRUG INJECTORS WHO USE NORTH AMERICA'S FIRST MEDICALLY SUPERVISED SAFER INJECTING FACILITY

Eitemau Tebyg

• Injection drug use cessation and use of North America's first medically supervised safer injecting facility
  gan: DeBeck, K.
• Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: a retrospective population-based study
  gan: Marshall, B.D.L
• IDU perspectives on the design and operation of North America's first medically supervised injection facility
  gan: Small, W.
• SAFER INJECTION FACILITIES IN NORTH AMERICA: THEIR PLACE IN PUBLIC POLICY AND HEALTH INITIATIVES
  gan: BROADHEAD, R.S
• ATTENDANCE, DRUG USE PATTERNS, AND REFERRALS MADE FROM NORTH AMERICA'S FIRST SUPERVISED INJECTION FACILITY
  gan: TYNDALL, M.W